Q2 2018 13F Holders as of 6/30/2018
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
33M
-
Number of holders
-
211
-
Total 13F shares, excl. options
-
30.5M
-
Shares change
-
-1.71M
-
Total reported value, excl. options
-
$2.6B
-
Value change
-
-$129M
-
Put/Call ratio
-
0.59
-
Number of buys
-
104
-
Number of sells
-
-98
-
Price
-
$85.46
Significant Holders of AMEDISYS INC - Common Stock, par value $0.001 per share (AMED) as of Q2 2018
247 filings reported holding AMED - AMEDISYS INC - Common Stock, par value $0.001 per share as of Q2 2018.
AMEDISYS INC - Common Stock, par value $0.001 per share (AMED) has 211 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 30.5M shares
of 33M outstanding shares and own 92.4% of the company stock.
Largest 10 shareholders include BlackRock Inc. (5.38M shares), VANGUARD GROUP INC (2.91M shares), Kohlberg Kravis Roberts & Co. L.P. (2.42M shares), WELLINGTON MANAGEMENT GROUP LLP (1.46M shares), AMERIPRISE FINANCIAL INC (1.13M shares), DIMENSIONAL FUND ADVISORS LP (1.11M shares), AMERICAN CENTURY COMPANIES INC (1.05M shares), WELLS FARGO & COMPANY/MN (971K shares), STATE STREET CORP (826K shares), and JPMORGAN CHASE & CO (815K shares).
This table shows the top 211 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.